More News

12 Dec 2016 Defymed Enters Partnership with Semma Therapeutics
12 Dec 2016 Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
10 Dec 2016 AstraZeneca and Lilly to develop second potentially disease-modifying treatment for Alzheimer’s disease
09 Dec 2016 Complimentary copy of report „Blockbuster Biologics 2015: Sales of Recombinant Therapeutic Antibodies & Proteins“
09 Dec 2016 Forge Therapeutics and Evotec Form Strategic 'Superbug' Alliance
09 Dec 2016 Renova Therapeutics secures novel AAV vector license for use in metabolic and cardiovascular gene therapy development
09 Dec 2016 TxCell signs in-licensing global agreement with Inserm Transfert for novel population of regulatory T cells
07 Dec 2016 Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS
07 Dec 2016 Cristal Therapeutics and iTeos Therapeutics announce strategic partnership for the development of immuno-oncology therapeutic candidates using Cristal’s CriPec® nanotech platform
07 Dec 2016 Sienna Biopharmaceuticals Acquires Creabilis plc
07 Dec 2016 Arcturus Therapeutics Announces Collaboration with Takeda Pharmaceuticals to Develop RNA-based Therapeutics for the Treatment of Nonalcoholic Steatohepatitis (NASH)
06 Dec 2016 PDC*line Pharma raises €4 million ($4.24M) in a first round and appoints Eric Halioua as president and CEO
05 Dec 2016 AbbVie and Northwestern University's Lurie Cancer Center to collaborate on multi-year cancer research agreement
05 Dec 2016 AbbVie and Johns Hopkins to Collaborate on Cancer Research
05 Dec 2016 Calimmune Expands Lentiviral Gene Therapy Pipeline Through License of Sickle Cell Disease Therapeutic Candidate
05 Dec 2016 Spark Therapeutics Enters into Licensing Agreement with Selecta Biosciences
05 Dec 2016 Sanofi and JHL Biotech Announce Strategic Biologics Alliance in China
01 Dec 2016 Parker Institute for Cancer Immunotherapy and Cancer Research Institute Launch Collaboration on Cancer Neoantigens
01 Dec 2016 Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics
30 Nov 2016 Sosei Subsidiaries Heptares to Acquire G7 Therapeutics to Extend Leadership in GPCR-focused Drug Discovery and Development
30 Nov 2016 Evotec and Merck Enter into Agreements to Collaborate on Target Discovery Technologies
29 Nov 2016 Allakos Expands License Agreement with The Johns Hopkins University School of Medicine
29 Nov 2016 MedImmune and Abpro Enter Into a Collaborative Agreement for a Novel Bispecific Antibody
29 Nov 2016 TxCell completes aligning operations with strategic refocus
29 Nov 2016 Idera Pharmaceuticals and Vivelix Pharmaceuticals, Ltd. Enter Into Exclusive License Agreement for the Worldwide Rights to IMO-9200

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top